MONICA NEALIS: Open Payments
NPI 1073676805 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 37 payments from 10 companies in 2025. Trend: 2023 $622 · 2024 $466 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $185 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 5 | $47 |
| Novo Nordisk Inc | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $14 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $5 |
Products named: VRAYLAR, Sunosi, QULIPTA, UBRELVY, GVOKE HYPOPEN, INSPIRE, MOUNJARO, XYWAV.
Industry payments across ID — which companies pay providers there.
